DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ slid 1.08% to $627.74 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.02% to 7,520.36 and the Dow Jones Industrial Average rising 0.36% to 50,644.28.
This was the stock's fourth consecutive day of losses.
Regeneron Pharmaceuticals Inc. closed 23.55% short of its 52-week high of $821.11, which the company reached on January 9th.
The stock underperformed when compared to some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ rose 0.04% to $336.06, Moderna Inc. (MRNA) rose 1.23% to $47.61, and Gilead Sciences Inc. (GILD) fell 0.03% to $133.69.
Trading volume (1.9 M) eclipsed its 50-day average volume of 800,621.
Data source: Dow Jones Market Data, FactSet. Data compiled May 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 27, 2026 16:46 ET (20:46 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.